Business Wire

VALBIOTIS Authorized to Launch HEART, the Phase II Multi-center Clinical Study With TOTUM-070, for the Reduction of Blood LDL-cholesterol Levels

Share

VALBIOTIS (FR0013254851 – ALVAL / eligible for the PEA/SME, French equity savings plan for the financing of SMEs) (Paris:ALVAL), a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces that it has received a positive opinion from the CPP and authorization from the ANSM to launch HEART, a multi-centric Phase II clinical study with TOTUM-070, for the reduction of blood LDL-cholesterol levels, a risk factor for cardiovascular disease.

The main objective of this clinical study is to evaluate the efficacy of a 5g daily dose of TOTUM-070 and to confirm its safety. HEART results will support the application for a proprietary health claim related to the reduction of LDL-cholesterol, a risk factor for cardiovascular disease.

These authorizations make it possible to begin enrolling 120 people with untreated mild to moderate LDL-hypercholesterolemia in the study.

Professor Jean-Marie Bard, PharmD, PhD, Professor and Hospital Practitioner at Nantes University Hospital, scientific advisor for the Phase II clinical study, declared: “The need for an additional, effective and well-tolerated tool in the clinical arsenal to rapidly reduce LDL-cholesterol without waiting for the situation to deteriorate is currently not fully met. TOTUM-070 offers, in this regard, new promise for patients with genuine cardiovascular risk. By acting on LDL-cholesterol, the risk of cardiovascular events is reduced with a positive impact on life expectancy. Improving cardiovascular prognosis is a major public health challenge. As an advisor to the HEART study, I have high hopes for the ability of TOTUM-070 to significantly reduce bad cholesterol levels in the blood.”

Murielle Cazaubiel, member of the Management Board, Head of Development and Medical Affairs at VALBIOTIS, added: “VALBIOTIS is very proud to bring its second active substance, TOTUM-070, to the Phase II clinical stage. The design of the HEART study will provide unequivocal proof of the efficacy of this active substance in hypercholesterolemic patients. This is a key milestone in the development of TOTUM-070 and an exciting prospect for those awaiting alternative solutions. With this second innovative active substance, VALBIOTIS consolidates its breakthrough position in the prevention of metabolic diseases.
We wish to warmly thank all the healthcare professionals involved in this study.”

The Phase II randomized, double-blind, placebo-controlled clinical study will include 120 people with untreated moderate hypercholesterolemia between 130 and 190 mg/dL. Participants will be divided into 2 equivalent arms of 60 people, supplemented for 6 months with TOTUM-070 or placebo. The primary endpoint of the study will be the reduction of blood LDL-cholesterol levels, with several secondary objectives of interest.

Results are expected at the beginning of 2022.

In line with VALBIOTIS' business model, the objective is to conclude a partnership and license agreement for the marketing of TOTUM-070 with a global healthcare player. In February 2020, this model enabled VALBIOTIS to sign a strategic partnership with Nestlé Health Science for the active substance TOTUM-63, aimed at reducing the risk of type 2 diabetes in prediabetic individuals.

ABOUT TOTUM-070
TOTUM-070 is an innovative active substance derived from food plant extracts, free from phytosterols and red rice yeast, developed to act on lipid metabolism in hypercholesterolemic subjects.
This exclusive active substance is especially developed for people with mild to moderate LDL-cholesterol levels, up to 190 mg/dL, untreated and associated with a moderate overall cardiovascular risk.
TOTUM-070 benefits from intellectual property backed by patents in the world's main markets: Europe, the United States, Russia, South Africa and national phases in progress in the United Arab Emirates, Brazil, Canada, Japan, China, Australia and Mexico.
The goal of TOTUM-070 clinical development is to obtain a proprietary health claim related to the reduction of blood LDL-cholesterol, a risk factor for cardiovascular disease.
Excess LDL-cholesterol is a widespread cardiovascular risk factor, found in nearly 40% of the world's adult population, according to WHO data.

ABOUT VALBIOTIS
VALBIOTIS is a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs.
VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of nutritional health solutions designed to reduce the risk of major metabolic diseases, based on a multi-target approach and made possible by the use of plant-based ingredients.
Its products are intended to be licensed to players in the health world.
VALBIOTIS was founded in La Rochelle in early 2014 and has formed numerous partnerships with top academic centers. The Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63).
VALBIOTIS is a member of the “BPI Excellence” network and received “Innovative Company“ status awarded by BPI France. Valbiotis has also been awarded “Young Innovative Company” status and has received major financial support from the European Union for its research programs via the European Regional Development Fund (ERDF). VALBIOTIS is a PEA-SME eligible company.
Find out more about VALBIOTIS: www.valbiotis.com

Name: VALBIOTIS
ISIN code: FR0013254851
Mnemonic code: ALVAL
EnterNext© PEA-SME 150

DISCLAIMER
This press release contains forward-looking statements about VALBIOTIS’ objectives, based on rational hypotheses and the information available to the company at the present time. However, in no way does this constitute a guarantee of future performance, and these projections may be affected by changes in economic conditions and financial markets, as well as a certain number of risks and uncertainties, including those described in the VALBIOTIS registration document, filed with the French Financial Markets Regulator (AMF) on 31 July 2020 (application number R 120-018). This document is available on the Company’s website (www.valbiotis.com).
This press release, as well as the information contained herein, does not constitute an offer to sell or subscribe to, or a solicitation to purchase or subscribe to, VALBIOTIS’ shares or securities in any country.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

VALBIOTIS / CORPORATE COMMUNICATION
Carole Rocher / Marc Delaunay
+33 5 46 28 62 58
media@valbiotis.com

ACTIFIN / FINANCIAL COMMUNICATION
Stéphane Ruiz
+33 1 56 88 11 14
sruiz@actifin.fr

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Norsk Titanium Lists On Euronext Growth After Successful USD $38 Million Capital Raise18.5.2021 16:15:00 CEST | Press release

Norsk Titanium AS (Norsk Titanium), a global leader in the additive manufacturing of aerospace-grade titanium components, has satisfied the conditions for listing on the Euronext Growth Oslo. Norsk Titanium’s first day of trading on the exchange was May 18th under the ticker code NTI. The listing follows a successful share issue through a private placement that raised approximately USD $38 million. Leading shareholders, represented on the Board of Directors, participated in the private placement with USD $15 million, and the Norwegian family-owned investment company Ferd AS participated with USD $10 million. Norsk Titanium intends to use the proceeds from the private placement to fund planned growth initiatives. “Today marks an important milestone for Norsk Titanium,” said Michael Canario, Norsk Titanium’s CEO. “The funding enabled through the Euronext Growth listing will support our ongoing development activities with our commercial customers as well as assist the transition of our te

How Dahua Technology Helps Prevent Forest Fires18.5.2021 15:45:00 CEST | Press release

It takes decades for trees to grow, yet only minutes for fires to destroy them. Forest fires are the type of natural disaster that strike with sudden destructiveness and are often difficult to control. That’s why working to prevent forest fires and the damage they cause to natural resources — as well as people’s property and sometimes human life — is a priority for Dahua Technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005588/en/ Dahua Solution Safeguarding The Yarlung Zangbo Grand Canyon (Photo: Business Wire) Over the years, Dahua Technology has developed and deployed capabilities for comprehensive technical support in forest and grassland fire monitoring as well as early warning, forecasting, rescue and post-disaster assessment with digital intelligence technology. Dahua’s technology fully integrates video perception systems with integrated sky and ground monitoring methods to form a strong "fire net" aime

Board International Strengthens Board of Directors to Drive Continued International Expansion and Accelerated Growth18.5.2021 15:35:00 CEST | Press release

Board International, the #1 SaaS Decision-Making-Platform vendor, announces today that Marco Limena will join the Board of Directors of the company as Non-Executive Director and Senior Advisor. Mr. Limena has held senior executive positions in leading technology corporations, including Microsoft, where he was based in Redmond, and at HP, based in Palo Alto. He has extensive experience working with leading Private Equity firms in multiple CEO assignments for B2B growth-oriented software businesses, and as Board Director in both private and publicly listed companies, and industry associations. Based in London, Marco Limena is CEO of TOMIA, a global provider of software solutions designed to accelerate the transformation and monetization of carriers’ connectivity business, with Data, Financial Clearing and BI solutions. Previously at Microsoft, Mr. Limena was Vice President of Hosting & Cloud, responsible for B2B commercial operations of the company’s cloud and infrastructure services bus

Pricefx Named a Finalist for 2021 SAP ® Pinnacle Award in the Partner of Year – Endorsed Apps Category18.5.2021 15:30:00 CEST | Press release

Pricefx, the global leader in cloud-native pricing software, today announced that it has been recognized by SAP as a finalist for a 2021 SAP® Pinnacle Award in the Partner of the Year – Endorsed Apps category. This award recognizes an SAP partner that has created a world-class SAP endorsed app that complements SAP technologies and has contributed a significant amount of value to SAP and its end customers. Last year, Pricefx was a finalist for SAP App Center Partner of the Year. The annual SAP Pinnacle Awards acknowledge the contributions of leading SAP partners that have excelled in developing and growing their partnership with SAP and helping customers meet their goals. Finalists and winners in 28 categories were chosen based on recommendations from SAP, customer feedback and performance indicators. SAP Endorsed Apps are premium certified by SAP with added security, in-depth testing and measurements against benchmarks results. A leader in price optimization, Pricefx’s SAP endorsed app

Andersen Global Broadens Coverage in Liechtenstein and Switzerland18.5.2021 15:30:00 CEST | Press release

Andersen Global adds legal capabilities in Liechtenstein and Switzerland through a Collaboration Agreement with NSF, strengthening the organization’s platform as it continues its expansion in the region. With offices in Vaduz and Zurich, NSF operates with five Partners and 40 professionals, serving individuals and international corporations. The full-service location in Liechtenstein provides a range of services in legal, trust and asset management with capabilities in banking and capital markets, tax, corporate, M&A, arbitration and dispute resolution, contracts, and administrative and constitutional law. Additionally, the office in Switzerland operates as an independent Swiss law firm and offers services in various areas of business law, such as criminal tax law, corporate/M&A, succession planning, inheritance law, litigation, restructuring, debt enforcement and insolvency, employment, financial markets as well as commercial contracts. “For more than 30 years, our extensive experienc

Heise Medien relies on the Xpublisher editorial system18.5.2021 15:04:00 CEST | Press release

Heise Medien GmbH & Co. KG, one of Germany’s leading tech industry publishers, succeeded in establishing transparent and well-organized content and media asset management together with a highly streamlined production process for its magazines by implementing Xpublisher. Xpublisher supports content utilization along the entire value chain, from planning, editorial creation, editing, and layout to the final publication, based on a “content first” approach. This enables Heise Medien to publish across multiple channels in a way that is highly efficient, cost effective, and error free. "We are pleased that Heise Medien trusts in our expertise and successfully automates their magazine production with our editorial system", says Matthias Kraus, CEO of Xpublisher. The numbers are a testament to the project’s success: Instead of the typical production phase of ten days, the first issue of c't was ready for printing in just nine days. In digital production, the company succeeded in both enhancin

Thales Announces New Solutions to Help Organisations Discover, Protect and Control Sensitive Data in Multicloud Environments18.5.2021 15:00:00 CEST | Press release

Thales today announced new data protection solutions for Google Cloud, Microsoft Azure, and Amazon Web Services, solidifying its role as a trusted third party for multicloud data security. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005282/en/ © Thales With each cloud provider having unique data protection mechanisms and key management offerings, multicloud data protection presents a complex security challenge for organisations. Thales’ latest cloud data security solutions allow customers to maintain control of and manage their encryption keys, as well as manage access and authentication across hybrid and multicloud environments. “These capabilities are critical to cloud migration and security, especially with such accelerated growth in this area,” said Sunil Potti, Vice President and General Manager of Google Cloud Security. “True to our mission, we have forged this collaboration with Thales to further protect our

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom